Catestatin and Hypertension in Pregnancy
NCT03200743 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2017-06-27
Summary
Catestatin is a kind of protein involved with cardiovascular disease. Accumulated evidence shows that Catestatin may be a predictor of primary hypertension, but whether it plays the same role in pregnant hypertensive disorders needs to be determined. By measuring the plasma level of Catestatin, main biochemical marks and UCG in healthy pregnancy and pregnancy with hypertension, the research may contribute to this problem.
Conditions
- Pre-Eclampsia
- Eclampsia
- Hypertension, Pregnancy-Induced
- Hypertension in Pregnancy
Sponsors & Collaborators
-
Yuchen Pan
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-14
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- China
More Related Trials
-
Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy
NCT03821922 ·Status: UNKNOWN
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
Effects of Dietary Nitrate in Hypertensive Pregnant Women
NCT02520687 ·Status: COMPLETED ·Phase: NA
-
L-arginine Effects on Chronic Hypertension in Pregnancy
NCT00974714 ·Status: COMPLETED ·Phase: PHASE3
-
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
NCT03298802 ·Status: RECRUITING ·Phase: PHASE3
-
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
NCT01682304 ·Status: COMPLETED
-
Understanding Post-translational Modifications to Circulating Histones Via Mass Spectrometry in Pregnant Women Developing Pre-eclampsia: A Retrospective Study
NCT05142410 ·Status: COMPLETED
-
The Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery Reactivity
NCT03888170 ·Status: WITHDRAWN
-
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NCT05934318 ·Status: RECRUITING ·Phase: NA
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Pregnancy Outcomes in Normotensive VS stage1 Hypertension: a Prospective Observational Study
NCT06339749 ·Status: RECRUITING
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA
-
Oral L-Citrulline and ADMA in Pregnancy
NCT00743210 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia
NCT01674127 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
B-vitamin Levels and Adverse Pregnancy Outcomes
NCT05073978 ·Status: COMPLETED
-
Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort
NCT04631627 ·Status: UNKNOWN ·Phase: PHASE4
-
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
NCT05016440 ·Status: WITHDRAWN ·Phase: NA
-
Losartan for Improved Vascular Endothelial Function After Preeclampsia
NCT04632589 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Elevated Blood Pressures in Early Pregnancy
NCT05955040 ·Status: TERMINATED ·Phase: PHASE2
-
Nutraceutical Citrulline in Pregnancy
NCT02772887 ·Status: TERMINATED ·Phase: NA
-
Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality
NCT05631067 ·Status: COMPLETED ·Phase: NA
-
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
NCT05500989 ·Status: RECRUITING
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1